154 related articles for article (PubMed ID: 9625172)
21. Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study.
Zhou J; Iwasa Y; Konishi I; Kan N; Kannagi R; Kobashi Y; Kim YC; Yamabe H
Cancer; 1995 Aug; 76(3):429-36. PubMed ID: 8625124
[TBL] [Abstract][Full Text] [Related]
22. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
23. BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.
Lavie O; Hornreich G; Ben-Arie A; Rennert G; Cohen Y; Keidar R; Sagi S; Lahad EL; Auslander R; Beller U
Gynecol Oncol; 2004 Feb; 92(2):521-4. PubMed ID: 14766242
[TBL] [Abstract][Full Text] [Related]
24. Primary papillary serous carcinoma of the peritoneum: report of a case with diagnosis by fine needle aspiration and immunocytochemistry.
Alberti N; Serrano-Egea A; García-García E; Ballestín C; Pérez-Barrios A; López-Ríos F; de Agustín P
Acta Cytol; 2007; 51(2):203-6. PubMed ID: 17425204
[TBL] [Abstract][Full Text] [Related]
25. Advanced ovarian carcinoma: molecular evidence of unifocal origin.
Li S; Han H; Resnik E; Carcangiu ML; Schwartz PE; Yang-Feng TL
Gynecol Oncol; 1993 Oct; 51(1):21-5. PubMed ID: 8244169
[TBL] [Abstract][Full Text] [Related]
26. No BRCA1 germline mutation in a family with uterine papillary serous carcinoma: a case report.
Pejovic T; Koul A; Olsen D; Chambers JT
Eur J Gynaecol Oncol; 2001; 22(5):336-8. PubMed ID: 11766733
[TBL] [Abstract][Full Text] [Related]
27. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
[TBL] [Abstract][Full Text] [Related]
28. Papillary serous carcinoma of the peritoneum in a man: a case report.
Shah IA; Jayram L; Gani OS; Fox IS; Stanley TM
Cancer; 1998 Mar; 82(5):860-6. PubMed ID: 9486574
[TBL] [Abstract][Full Text] [Related]
29. Field cancerization: why late "recurrent" ovarian cancer is not recurrent.
Buller RE; Skilling JS; Sood AK; Plaxe S; Baergen RN; Lager DJ
Am J Obstet Gynecol; 1998 Apr; 178(4):641-9. PubMed ID: 9579425
[TBL] [Abstract][Full Text] [Related]
30. Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier.
Piura B; Rabinovich A; Yanai-Inbar I
Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):241-4. PubMed ID: 11451557
[TBL] [Abstract][Full Text] [Related]
31. Xp22.2-3 loss of heterozygosity is associated with germline BRCA1 mutation in ovarian cancer.
Buekers TE; Lallas TA; Buller RE
Gynecol Oncol; 2000 Mar; 76(3):418-22. PubMed ID: 10684722
[TBL] [Abstract][Full Text] [Related]
32. High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associations.
Rzepecka IK; Szafron L; Stys A; Bujko M; Plisiecka-Halasa J; Madry R; Osuch B; Markowska J; Bidzinski M; Kupryjanczyk J
Cancer Genet; 2012 Mar; 205(3):94-100. PubMed ID: 22469508
[TBL] [Abstract][Full Text] [Related]
33. Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.
Jacobs IJ; Kohler MF; Wiseman RW; Marks JR; Whitaker R; Kerns BA; Humphrey P; Berchuck A; Ponder BA; Bast RC
J Natl Cancer Inst; 1992 Dec; 84(23):1793-8. PubMed ID: 1433368
[TBL] [Abstract][Full Text] [Related]
34. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
35. Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Werness BA; Parvatiyar P; Ramus SJ; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio RA; Wiest J; Tsukada Y; Ponder BA; Piver MS
J Natl Cancer Inst; 2000 Jul; 92(13):1088-91. PubMed ID: 10880552
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serous peritoneal carcinoma.
Wang PH; Shyong WY; Li YF; Lee HH; Tsai WY; Chao HT; Wu CY; Tsai YC; Yuan CC
Jpn J Clin Oncol; 2000 Aug; 30(8):343-8. PubMed ID: 11059339
[TBL] [Abstract][Full Text] [Related]
37. Molecular evidence for the independent origin of extra-ovarian papillary serous tumors of low malignant potential.
Gu J; Roth LM; Younger C; Michael H; Abdul-Karim FW; Zhang S; Ulbright TM; Eble JN; Cheng L
J Natl Cancer Inst; 2001 Aug; 93(15):1147-52. PubMed ID: 11481386
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal serous papillary carcinoma, a phenotypic variant of familial ovarian cancer: implications for ovarian cancer screening.
Karlan BY; Baldwin RL; Lopez-Luevanos E; Raffel LJ; Barbuto D; Narod S; Platt LD
Am J Obstet Gynecol; 1999 Apr; 180(4):917-28. PubMed ID: 10203660
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.
Olivier RI; van Beurden M; Lubsen MA; Rookus MA; Mooij TM; van de Vijver MJ; van't Veer LJ
Br J Cancer; 2004 Apr; 90(8):1492-7. PubMed ID: 15083174
[TBL] [Abstract][Full Text] [Related]
40. Androgen receptor gene methylation and exon one CAG repeat length in ovarian cancer: differences from breast cancer.
Kassim S; Zoheiry NM; Hamed WM; Going JJ; Craft JA
IUBMB Life; 2004 Jul; 56(7):417-26. PubMed ID: 15545219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
